CENTA Stock Analysis: Central Garden & Pet | NASDAQ

Pet Supplies, Garden Supplies, Animal Health, Bird Feed

Total Rating 49

Safety 82

Buy Signal -0.09

Packaged Foods
Industry Rotation: -1.3

Market Cap: 2.37B
Avg Turnover: 12.0M

Risk 3d forecast

Volatility29.7%

VaR 5^th Pctl4.67%

VaR vs Median-4.61%

Reward TTM

Sharpe Ratio0.30

Rel. Str. IBD55.1

Rel. Str. Peer Group70.8

Character TTM

Beta0.063

Beta Downside-0.051

Hurst Exponent0.560

Drawdowns 3y

Max DD35.68%

CAGR/Max DD0.14

CAGR/Mean DD0.32

EPS (Earnings per Share)

EPS CAGR: 12.58%
EPS Trend: 89.1%

Last SUE: 0.47
Qual. Beats: 0

Revenue

Rev. CAGR: -2.78%
Rev. Trend: -92.9%

Last SUE: -0.27
Qual. Beats: 0

Warnings

Below Avwap Earnings

Tailwinds

Shakeout

Seasonality 11.6 years of data

Jan -1.5% 8

Feb -1.4% 2

Mar +1.0% 5

Apr -2.7% 19

May +3.5% 46

Jun -0.8% 8

Jul +0.4% 19

Aug -0.6% 2

Sep -3.6% 30

Oct -3.6% 41

Nov +1.3% 11

Dec +0.4% 0

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: CENTA Central Garden & Pet

Central Garden & Pet Company (NASDAQ: CENTA) is a U.S.-based manufacturer and distributor serving two consumer-facing markets: pet supplies and lawn & garden products. The company is structured around two operating segments - Pet and Garden - through which it offers branded products across dog/cat care, aquatics and small animals, equine and livestock, wild bird feeding, lawn seed, fertilizers, and pest control. Its portfolio includes well-known brands such as Nylabone, Kaytee, Aqueon, K&H, Pennington, Amdro, and Sevin, with products sold via independent distributors, big-box and national/regional retail chains, grocery stores, mass merchants, nurseries, and online/eCommerce channels.

The Pet segment is the larger of the two by revenue contribution, reflecting the companys heavy exposure to the broad pet care category, an industry where premiumization, humanization of pets, and growing pet ownership have historically supported volume and pricing. Founded in 1955 and headquartered in Walnut Creek, California, Central Garden & Pet has grown largely through bolt-on acquisitions, a strategy common in the fragmented household and lawn/garden products sub-industry, allowing it to extend brand depth, expand shelf space with mass retailers, and broaden its multi-category offerings to retail partners. The company trades as a mid-cap stock within the Consumer Staples sector and has been publicly listed since 1993.

Headlines to Watch Out For

Pet segment organic revenue growth offsets weather-exposed Garden sales
Raw material and freight cost inflation pressures consolidated gross margins
Acquisitions of pet brands expand portfolio and drive market share gains

Piotroski VR-10 (Strict) 5.5

Net Income: 166.3m TTM > 0 and > 6% of Revenue
FCF/TA: 0.09 > 0.02 and ΔFCF/TA 0.58 > 1.0
NWC/Revenue: 50.94% < 20% (prev 46.09%; Δ 4.85% < -1%)
CFO/TA 0.10 > 3% & CFO 390.3m > Net Income 166.3m
Net Debt (627.4m) to EBITDA (391.9m): 1.60 < 3
Current Ratio: 3.79 > 1.5 & < 3
Outstanding Shares: last quarter (61.9m) vs 12m ago -3.63% < -2%
Gross Margin: 32.54% > 18% (prev 31.08%; Δ 1.46% > 0.5%)
Asset Turnover: 82.82% > 50% (prev 85.32%; Δ -2.49% > 0%)
Interest Coverage Ratio: 4.66 > 6 (EBIT TTM 266.9m / Interest Expense TTM 57.2m)

Altman Z'' 5.11

A: 0.41 (Total Current Assets 2.13b - Total Current Liabilities 563.7m) / Total Assets 3.79b
B: 0.31 (Retained Earnings 1.18b / Total Assets 3.79b)
C: 0.07 (EBIT TTM 266.9m / Avg Total Assets 3.72b)
D: 0.85 (Book Value of Equity 1.75b / Total Liabilities 2.04b)
Altman-Z'' = 5.11 = AAA

Beneish M -3.17

DSRI: 0.89 (Receivables 460.2m/522.7m, Revenue 3.08b/3.12b)
GMI: 0.95 (GM 31.08% / 32.54%)
AQI: 1.01 (AQ_t 0.29 / AQ_t-1 0.29)
SGI: 0.99 (Revenue 3.08b / 3.12b)
TATA: -0.06 (NI 166.3m - CFO 390.3m) / TA 3.79b)
Beneish M = -3.17 (Cap -4..+1) = AA

What is the price of CENTA shares?

As of September 03, 2026, the stock is trading at USD 36.64 with a total of 349,895 shares traded. Over the past week, the price has changed by -4.03%, over one month by -4.06%, over three months by +8.05% and over the past year by +9.31%.

Current recommended Stop Loss: 34.70 (which is 5.3% or 1.8 ATR below the current price).

Is CENTA a buy, sell or hold?

Central Garden & Pet has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy CENTA.

StrongBuy: 3
Buy: 1
Hold: 3
Sell: 0
StrongSell: 0

What are the forecasts/targets for the CENTA price?

Analysts Target Price	46.3	26.2%

Central Garden & Pet (CENTA) - Fundamental Data Overview as of 30 August 2026

Market Cap USD = 2.37b (2.37b USD * 1.0 USD.USD)
P/E Trailing = 14.0037
P/E Forward = 11.655
P/S = 0.7674
P/B = 1.3534
P/EG = 1.866
Revenue TTM = 3.08b USD
EBIT TTM = 266.9m USD
EBITDA TTM = 391.9m USD
Long Term Debt = 1.19b USD (from longTermDebt, last quarter)
Short Term Debt = 50.7m USD (from shortTermDebt, last quarter)
Debt = 1.62b USD (from shortLongTermDebtTotal, last quarter) + Leases 215.5m
Net Debt = 627.4m USD (calculated: Debt 1.62b - CCE 996.7m)
Enterprise Value = 2.99b USD (2.37b + Debt 1.62b - CCE 996.7m)
Interest Coverage Ratio = 4.66 (Ebit TTM 266.9m / Interest Expense TTM 57.2m)
EV/FCF = 8.66x (Enterprise Value 2.99b / FCF TTM 345.6m)
FCF Yield = 11.54% (FCF TTM 345.6m / Enterprise Value 2.99b)
FCF Margin = 11.21% (FCF TTM 345.6m / Revenue TTM 3.08b)
Net Margin = 5.39% (Net Income TTM 166.3m / Revenue TTM 3.08b)
Gross Margin = 32.54% ((Revenue TTM 3.08b - Cost of Revenue TTM 2.08b) / Revenue TTM)
Gross Margin QoQ = 35.92% (prev 33.06%)
Tobins Q-Ratio = 0.79 (Enterprise Value 2.99b / Total Assets 3.79b)
Interest Expense / Debt = 3.52% (Interest Expense 57.2m / Debt 1.62b)
Taxrate = 24.15% (52.9m / 219.2m)
NOPAT = 202.4m (EBIT 266.9m * (1 - 24.15%))
Current Ratio = 3.79 (Total Current Assets 2.13b / Total Current Liabilities 563.7m)
Debt / Equity = 0.93 (Debt 1.62b / totalStockholderEquity, last quarter 1.75b)
Debt / EBITDA = 1.60 (Net Debt 627.4m / EBITDA 391.9m)
Debt / FCF = 1.82 (Net Debt 627.4m / FCF TTM 345.6m)
Total Stockholder Equity = 1.64b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.47% (Net Income 166.3m / Total Assets 3.79b)
RoE = 10.15% (Net Income TTM 166.3m / Total Stockholder Equity 1.64b)
RoCE = 9.42% (EBIT 266.9m / Capital Employed (Equity 1.64b + L.T.Debt 1.19b))
RoIC = 6.48% (NOPAT 202.4m / Invested Capital 3.12b)
WACC = 4.76% (E(2.37b)/V(3.99b) * Re(6.20%) + D(1.62b)/V(3.99b) * Rd(3.52%) * (1-Tc(0.24)))
Discount Rate = 6.20% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -96.65 | Cagr: -3.32%
[DCF] Terminal Value 76.74% ; FCFF base≈332.3m ; Y1≈363.1m ; Y5≈455.6m
[DCF] Fair Price = 123.5 (EV 6.97b - Net Debt 627.4m = Equity 6.34b / Shares 51.3m; r=8.35% [WACC [floored]]; 5y FCF grow 10.69% → 2.50% )
EPS Correlation: 89.10 | EPS CAGR: 12.58% | SUE: 0.47 | # QB: 0
Revenue Correlation: -92.87 | Revenue CAGR: -2.78% | SUE: -0.27 | # QB: 0
EPS current Quarter (2026-12-31): EPS=0.13 | Chg30d=-33.33% | Revisions=-25% | Analysts=2
EPS current Year (2026-09-30): EPS=2.97 | Chg30d=+0.24% | Revisions=+17% | GrowthEPS=+8.9% | GrowthRev=-3.7%
EPS next Year (2027-09-30): EPS=3.12 | Chg30d=+1.17% | Revisions=+17% | GrowthEPS=+5.0% | GrowthRev=-2.1%
[Analyst] Revisions Ratio: +10% (up=4, down=3)